MIMOS’ healthcare technology programme, which was initiated in 2013 as the Healthcare Information Technology Framework, is intended to support the needs of the Ministry of Health in particular, and that of the Malaysian public in general. Now better known as MIMOS Smart Healthcare, upgrades and enhancements of the initiatives involve growing use of Industry 4.0 technologies such as Big Data and Artificial Intelligence, particularly for healthcare provider central database and decision support systems. For devices and applications, photonics technology and IoT are also employed.
Healthcare systemsTeleprimary Care – Oral Health Clinical Information System (TPC-OHCIS)
The unified digital medical record system incorporates patients’ information and records from health and dental clinics. Since its launch, the system has shown increased efficiency in the patients’ record management including faster patient registration process, better lab turnaround time, improved efficiency in making appointments, and reduction of appointment defaulters for Maternal and Child Health and Non-Communicable Diseases. Other improvements include efficiency in outreach activities, billing process and report generation.
Malaysian Health Data Warehouse (MyHDW)
MyHDW is a comprehensive system that integrates critical medical information from various public and private healthcare systems nationwide. The system is built with local technology, thus reducing the dependency on foreign support. Since its implementation, it has reduced overheads and burden of data collection, processing and reporting. It has also improved overall analysis and delivery time.
Devices and applicationsGlucoSenz
GlucoSenz is possibly the world’s first clinically-tested non-invasive, non-intrusive and non-destructive blood screening prototype. The device uses chemometrics methods to study the near-infrared (NIRS) obtained in absorbance mode via the user’s thumb spectra. Through the use of photonics, electronics and software technologies, the device will detect, analyse and predict blood glucose level from the blood capillaries of the human thumb without piercing the skin.
The wearable brain-imaging device prototype can perform hemodynamic analysis on the brain. Using functional Near-Infrared Spectroscopy (fNIRS) as core technology, the headband is expected to complement Magnetic Resonance Imaging (MRI) scan for early detection of Mild Cognitive Impairment and Alzheimer’s disease. The headband can give a relatively more accurate analysis as the fNIRS equipment can quantify the degree of Alzheimer’s disease in order to classify the Dementia classes or categories.
MIMOS has collaborated with Universiti Kebangsaan Malaysia to work on dental applications that will further improve diagnosis of dental diseases, which is expected to bring positive impact to patient management, public health and ultimately help the nation to achieve general health benefits and mental wellbeing from citizens’ good oral health.